CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, /PRNewswire/ -- Harbour BioMed (HBM or the Company; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development ...
Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback